Abstract
Obesity in pregnancy is associated with cardiovascular disease, metabolic syndrome, and obesity in offspring. Animal studies demonstrate endothelial dysfunction in offspring of obese mothers. Endocan is a biomarker for endothelial dysfunction. Our group previously found a positive association between maternal obesity and neonatal endocan levels at birth. Our objective is to assess whether endocan levels at birth are associated with pediatric obesity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
